JMP Securities analyst Jonathan Wolleben reiterated a Buy rating on KalVista Pharmaceuticals (KALV – Research Report) today and set a price ...

JMP Securities maintained its optimistic stance on AtriCure Inc. (NASDAQ:ATRC), reiterating a Market Outperform rating and a $60.00 price target. The firm's analysts highlighted their anticipation for ...

JMP Securities analyst Jason Butler maintained a Buy rating on Cytokinetics (CYTK – Research Report) today and set a price target of $78.00.

As the US stock markets were catching up with the tech disruption led by cheap Chinese AI models, US President Donald Trump’s ...

JMP Securities maintained a bullish stance on Snap Inc (NYSE: NYSE:SNAP), reiterating their Market Outperform rating with a $16.00 price target. The endorsement follows Snap's release of its ...

KBC Group NV increased its holdings in Sabra Health Care REIT, Inc. (NASDAQ:SBRA – Free Report) by 66.2% in the fourth ...

Even with its well-documented benefits, DoE is often underutilised, especially for solving specialised or constrained ...

Diversify Wealth Management LLC lifted its holdings in shares of Option Care Health, Inc. (NASDAQ:OPCH – Free Report) by 31.7% in the 4th quarter, Holdings Channel reports. The institutional investor ...

Exposure to and the opportunity to acquire proficiency in essential technology including Statistical Analysis System (SAS), JMP and R; a JMP software license is included in tuition, a value of more ...